HETEROCYCLES, Vol. 88, No. 2, 2014
1549
1
2
(
1R,2R)-N ,N -Bis(2-(pyridin-2-yloxy)phenyl)-1,2-cyclohexanediamine (12). To a suspension of NaH
1
2
(
60% in oil, 132 mg, 3.29 mmol) in DMF (3.3 mL) was added (1R,2R)-N ,N -bis(2-hydroxyphenyl)-1,2-
cyclohexanediamine dihydrochloride (11) and 2-fluoropyridine (0.283 mL, 3.29 mmol). After stirring at
20 °C for 2 days, to the resulting mixture were added water (5 mL) and Et O (5 mL), and the aqueous
1
2
layer was extracted with Et O (5 mL × 2). The combined organic layers were washed with water (10 mL)
2
and brine (5 mL), dried over Na SO , and evaporated. The residue was purified by silica gel
2
4
1
2
chromatography (hexane/EtOAc = 4/1) to afford (1R,2R)-N ,N -bis(2-(pyridin-2-yloxy)phenyl)-1,2-
1
cyclohexanediamine (12) (103 mg, 35%) as a clear viscous liquid: R = 0.35 (hexane/EtOAc = 2/1); H
f
NMR (400 MHz, CDCl ): δ 8.14 (d, J = 5.1 Hz, 2H), 7.51 (dd, J = 8.0, 7.0 Hz, 2H), 7.01 (dd, J = 8.0, 7.6
3
Hz, 2H), 6.93 (d, J = 7.6 Hz, 2H), 6.90 (dd, J = 7.0, 5.1 Hz, 2H), 6.71 (d, J = 8.0 Hz, 2H), 6.70 (d, J = 8.0
1
Hz, 2H), 6.34 (dd, J = 7.6, 7.6 Hz, 2H), 4.09 (br, 2H), 3.20 (br, 2H), 2.09 (br, 2H), 1.23 (br, 6H); H
NMR (400 MHz, DMSO-d ): δ 8.06 (d, J = 4.9 Hz, 2H), 7.67 (dd, J = 8.2, 6.8 Hz, 2H), 7.01 (dd, J = 6.8,
6
4
.9 Hz, 2H), 6.94 (dd, J = 7.7, 7.7 Hz, 2H), 6.83 (d, J = 8.2 Hz, 2H), 6.77 (d, J = 7.7 Hz, 2H), 6.75 (d, J =
.7 Hz, 2H), 6.53 (dd, J = 7.7, 7.7 Hz, 2H), 4.54 (br, 2H), 3.28 (br, 2H), 1.92 (br, 2H), 1.58 (br, 2H), 1.18
7
1
3
(
br, 4H); C NMR (100 MHz, CDCl ): δ 163.5, 147.8, 141.1, 140.4, 139.3, 125.9, 121.5, 118.4, 116.7,
3
1
1
4
12.3, 110.4, 56.4, 31.7, 24.0; IR (ATR): 3394.8, 3056.8, 2930.3, 2855.7, 1606.3, 1509.7, 1466.3, 1424.5,
-1
28
D
+
234.9, 736.5 cm ; [α]
+1.36 (c 0.012, CHCl ); HRMS (ESI) calcd. for C H O N Na [M+Na ]
3 28 28 2 4
75.2104, found 475.2110.
(3aR,7aR)-1,3-Bis(2-(pyridin-2-yloxy)phenyl)-3a,4,5,6,7,7a-hexahydrobenzoimidazolium
tetrafluoroborate (14a). According to general procedure, (3aR,7aR)-1,3-bis(2-(pyridin-2-yloxy)phenyl)-
1
2
3
a,4,5,6,7,7a-hexahydrobenzoimidazolium tetrafluoroborate (14a) was prepared from (1R,2R)-N ,N -
bis(2-(pyridin-2-yloxy)phenyl)-1,2-cyclohexanediamine (12) (13.1 mg, 0.029 mmol) and NH BF (3.6
4
4
mg, 0.034 mmol). The NMR yield was obtained using phenanthrene (4.9 mg, 0.028 mmol) as an internal
1
standard (59%): R = 0.28 (DCM/MeOH = 10/1); H-NMR (400 MHz, DMSO-d ): δ 9.47 (s, 1H), 8.11 (d,
f
6
J = 5.0 Hz, 2H), 7.84 (dd, J = 8.2, 6.9 Hz, 2H), 7.60 (d, J = 7.8 Hz, 2H), 7.55 (dd, J = 7.8, 7.8 Hz, 2H),
7
.42 (dd, J = 7.8, 7.8 Hz, 2H), 7.33 (d, J = 7.8 Hz, 2H), 7.17 (dd, J = 6.9, 5.0 Hz, 2H), 7.02 (d, J = 8.2 Hz,
13
2
H), 3.92 (br, 2H), 2.06 (br, 2H), 1.76 (br, 2H), 1.42 (br, 2H), 1.19 (br, 2H); C NMR (100 MHz,
DMSO-d6): δ 161.7, 160.6, 148.2, 147.4, 140.8, 130.8, 126.9, 126.8, 125.8, 123.2, 120.1, 111.7, 69.5,
–
2
7.0, 23.1; HRMS (ESI) calcd. for C H O N [M-BF ] 463.2129, found 463.2129.
2
9
27
2
4
4
(3aR,7aR)-1,3-Bis(2-(pyridin-2-yloxy)phenyl)-3a,4,5,6,7,7a-hexahydrobenzoimidazolium
chloride
(14b). According to general procedure, (3aR,7aR)-1,3-bis(2-(pyridin-2-yloxy)phenyl)-3a,4,5,6,7,7a-
1
2
hexahydrobenzoimidazolium chloride (14-Cl) was prepared from (1R,2R)-N ,N -bis(2-(pyridin-2-
yloxy)phenyl)-1,2-cyclohexanediamine (12) (13.4 mg, 0.030 mmol) and NH Cl (1.9 mg, 0.036 mmol).
4
The NMR yield was obtained using phenanthrene (5.3 mg, 0.030 mmol) as an internal standard (73%): Rf